Drug Shortage Report for MYLAN-ATAZANAVIR
Report ID | 96531 |
Drug Identification Number | 02456877 |
Brand name | MYLAN-ATAZANAVIR |
Common or Proper name | ATAZANAVIR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ATAZANAVIR |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 60 BT |
ATC code | J05AE |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-11-01 |
Actual start date | 2019-11-01 |
Estimated end date | 2020-07-28 |
Actual end date | 2020-07-17 |
Shortage status | Resolved |
Updated date | 2020-07-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2020-07-14 | French | Compare |
v22 | 2020-07-31 | English | Compare |
v23 | 2020-07-31 | French | Compare |